A systematic review of the efficacy of hydroxychloroquine in COVID-19 patients

<p>Hydroxychloroquine is a highly effective and commonly used disease-modifying anti-rheumatic drug (DMRD) for the treatment of various autoimmune diseases. Recently this medication received lot of attention in the medical world as a potential treatment for COVID-19. The goal of this research is to perform a systematic review of literature to focus on the efficacy of hydroxychloroquine in COVID-19 patients and any evidence of adverse reactions. The database used to conduct this research was PubMed, using four keywords and phrases: effects, side effects, adverse events, and serious adverse events of hydroxychloroquine in COVID-19 patients. Out of the 15 articles selected for the final review, 12 articles indicated no clinical improvement and 10 articles did not indicate any evidence of adverse reactions. The conclusion of the research is that hydroxychloroquine indicates lack of efficacy as treatment in patients with COVID-19, and there is not enough conclusive evidence for adverse reactions.</p>

Name thesis:degree_name

Master of Science (MS)

Level thesis:degree_level

Open Access Thesis

Discipline thesis:degree_discipline

Health Sciences

Year dc:date.available

2021

Author dc:creator

• Joseph, Soumy Maria

Contributors dc:contributor

• Michael Switzer, Ph.D.
• Jean Rowan, MD, MS

• Adverse Events
• COVID-19 Patients
• Effects
• Hydroxychloroquine
• Serious Adverse Events
• Side Effects
• Medicine and Health Sciences

Repository record dc:identifier

https://commons.emich.edu/theses/1107

OAI identifier oai:identifier

oai:commons.emich.edu:theses-2481